Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study

Andre Manfred Willasch,Christina Peters,Adriana Balduzzi,Jean-Hugues Dalle,Marco Zecca,Amal Al-Seraihy,Franco Locatelli,Yves Bertrand,Stephen Robinson, Tracey OBrien,Amos Toren,Dragana S. Vujic,Jacques-Olivier Bay,Charlotte Jubert,Maura Faraci,Fanny Rialland,Vassiliki Kitra-Roussou,Gerard Michel,Mariacristina Menconi,Franca Fagioli

Blood（2021）

引用 0|浏览8

暂无评分

摘要

Background: Pediatric patients younger than two years of age with acute myeloid leukemia (AML) commonly receive a chemotherapy-based myeloablative conditioning regimen before allogeneic hematopoietic stem cell transplantation (HSCT). The optimal choice of cytotoxic agents is still controversial.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要